225 related articles for article (PubMed ID: 33194587)
1. Pre-clinical Research on Bladder Toxicity After Radiotherapy for Pelvic Cancers: State-of-the Art and Challenges.
Zuppone S; Bresolin A; Spinelli AE; Fallara G; Lucianò R; Scarfò F; Benigni F; Di Muzio N; Fiorino C; Briganti A; Salonia A; Montorsi F; Vago R; Cozzarini C
Front Oncol; 2020; 10():527121. PubMed ID: 33194587
[TBL] [Abstract][Full Text] [Related]
2. Small animal radiotherapy research platforms.
Verhaegen F; Granton P; Tryggestad E
Phys Med Biol; 2011 Jun; 56(12):R55-83. PubMed ID: 21617291
[TBL] [Abstract][Full Text] [Related]
3. Pelvic Complications After Prostate Cancer Radiation Therapy and Their Management: An International Collaborative Narrative Review.
Matta R; Chapple CR; Fisch M; Heidenreich A; Herschorn S; Kodama RT; Koontz BF; Murphy DG; Nguyen PL; Nam RK
Eur Urol; 2019 Mar; 75(3):464-476. PubMed ID: 30573316
[TBL] [Abstract][Full Text] [Related]
4. Toxicity assessment of pelvic intensity-modulated radiotherapy with hypofractionated simultaneous integrated boost to prostate for intermediate- and high-risk prostate cancer.
McCammon R; Rusthoven KE; Kavanagh B; Newell S; Newman F; Raben D
Int J Radiat Oncol Biol Phys; 2009 Oct; 75(2):413-20. PubMed ID: 19362783
[TBL] [Abstract][Full Text] [Related]
5. Bladder spatial-dose descriptors correlate with acute urinary toxicity after radiation therapy for prostate cancer.
Improta I; Palorini F; Cozzarini C; Rancati T; Avuzzi B; Franco P; Degli Esposti C; Del Mastro E; Girelli G; Iotti C; Vavassori V; Valdagni R; Fiorino C
Phys Med; 2016 Dec; 32(12):1681-1689. PubMed ID: 27570122
[TBL] [Abstract][Full Text] [Related]
6. Preliminary report of toxicity following 3D radiation therapy for prostate cancer on 3DOG/RTOG 9406.
Michalski JM; Purdy JA; Winter K; Roach M; Vijayakumar S; Sandler HM; Markoe AM; Ritter MA; Russell KJ; Sailer S; Harms WB; Perez CA; Wilder RB; Hanks GE; Cox JD
Int J Radiat Oncol Biol Phys; 2000 Jan; 46(2):391-402. PubMed ID: 10661346
[TBL] [Abstract][Full Text] [Related]
7. Cancer survivorship issues with radiation and hemorrhagic cystitis in gynecological malignancies.
Zwaans BMM; Lamb LE; Bartolone S; Nicolai HE; Chancellor MB; Klaudia SW
Int Urol Nephrol; 2018 Oct; 50(10):1745-1751. PubMed ID: 30132277
[TBL] [Abstract][Full Text] [Related]
8. Acute toxicity of image-guided hypofractionated radiotherapy for prostate cancer: nonrandomized comparison with conventional fractionation.
Jereczek-Fossa BA; Zerini D; Fodor C; Santoro L; Cambria R; Garibaldi C; Tagaste B; Vavassori A; Cattani F; Alterio D; Gherardi F; Serafini F; Rocco B; Musi G; De Cobelli O; Orecchia R
Urol Oncol; 2011; 29(5):523-32. PubMed ID: 20005749
[TBL] [Abstract][Full Text] [Related]
9. Dual benefit of supplementary oral 5-aminolevulinic acid to pelvic radiotherapy in a syngenic prostate cancer model.
Miyake M; Tanaka N; Hori S; Ohnishi S; Takahashi H; Fujii T; Owari T; Ohnishi K; Iida K; Morizawa Y; Gotoh D; Itami Y; Nakai Y; Inoue T; Anai S; Torimoto K; Aoki K; Fujimoto K
Prostate; 2019 Mar; 79(4):340-351. PubMed ID: 30450646
[TBL] [Abstract][Full Text] [Related]
10. Relationships between bladder dose-volume/surface histograms and acute urinary toxicity after radiotherapy for prostate cancer.
Carillo V; Cozzarini C; Rancati T; Avuzzi B; Botti A; Borca VC; Cattari G; Civardi F; Esposti CD; Franco P; Girelli G; Maggio A; Muraglia A; Palombarini M; Pierelli A; Pignoli E; Vavassori V; Zeverino M; Valdagni R; Fiorino C
Radiother Oncol; 2014 Apr; 111(1):100-5. PubMed ID: 24631144
[TBL] [Abstract][Full Text] [Related]
11. Dose constraints in the rectum and bladder following carbon-ion radiotherapy for uterus carcinoma: a retrospective pooled analysis.
Okonogi N; Fukahori M; Wakatsuki M; Ohkubo Y; Kato S; Miyasaka Y; Tsuji H; Nakano T; Kamada T
Radiat Oncol; 2018 Jun; 13(1):119. PubMed ID: 29941040
[TBL] [Abstract][Full Text] [Related]
12. Predictors for chronic urinary toxicity after the treatment of prostate cancer with adaptive three-dimensional conformal radiotherapy: dose-volume analysis of a phase II dose-escalation study.
Harsolia A; Vargas C; Yan D; Brabbins D; Lockman D; Liang J; Gustafson G; Vicini F; Martinez A; Kestin LL
Int J Radiat Oncol Biol Phys; 2007 Nov; 69(4):1100-9. PubMed ID: 17967304
[TBL] [Abstract][Full Text] [Related]
13. CT imaging markers to improve radiation toxicity prediction in prostate cancer radiotherapy by stacking regression algorithm.
Mostafaei S; Abdollahi H; Kazempour Dehkordi S; Shiri I; Razzaghdoust A; Zoljalali Moghaddam SH; Saadipoor A; Koosha F; Cheraghi S; Mahdavi SR
Radiol Med; 2020 Jan; 125(1):87-97. PubMed ID: 31552555
[TBL] [Abstract][Full Text] [Related]
14. [Normal tissue tolerance to external beam radiation therapy: bladder].
Pointreau Y; Atean I; Durdux C
Cancer Radiother; 2010 Jul; 14(4-5):363-8. PubMed ID: 20435498
[TBL] [Abstract][Full Text] [Related]
15. Adaptive radiotherapy strategies for pelvic tumors - a systematic review of clinical implementations.
Thörnqvist S; Hysing LB; Tuomikoski L; Vestergaard A; Tanderup K; Muren LP; Heijmen BJ
Acta Oncol; 2016 Aug; 55(8):943-58. PubMed ID: 27055486
[TBL] [Abstract][Full Text] [Related]
16. Squamous cell carcinoma of the urinary bladder: Systematic review of clinical characteristics and therapeutic approaches.
Martin JW; Carballido EM; Ahmed A; Farhan B; Dutta R; Smith C; Youssef RF
Arab J Urol; 2016 Sep; 14(3):183-91. PubMed ID: 27547458
[TBL] [Abstract][Full Text] [Related]
17. Regarding: Rosenthal DI, Glatstein E. "We've Got a Treatment, but What's the Disease?" The Oncologist 1996;1.
Lunsford LD; Flickinger JC; Larson D
Oncologist; 1997; 2(1):59-61. PubMed ID: 10388030
[TBL] [Abstract][Full Text] [Related]
18. A treatment planning and acute toxicity comparison of two pelvic nodal volume delineation techniques and delivery comparison of intensity-modulated radiotherapy versus volumetric modulated arc therapy for hypofractionated high-risk prostate cancer radiotherapy.
Myrehaug S; Chan G; Craig T; Weinberg V; Cheng C; Roach M; Cheung P; Sahgal A
Int J Radiat Oncol Biol Phys; 2012 Mar; 82(4):e657-62. PubMed ID: 22245189
[TBL] [Abstract][Full Text] [Related]
19. A review of treatment planning for precision image-guided photon beam pre-clinical animal radiation studies.
Verhaegen F; van Hoof S; Granton PV; Trani D
Z Med Phys; 2014 Dec; 24(4):323-34. PubMed ID: 24629309
[TBL] [Abstract][Full Text] [Related]
20. Pelvic nodal dose escalation with prostate hypofractionation using conformal avoidance defined (H-CAD) intensity modulated radiation therapy.
Hong TS; Tomé WA; Jaradat H; Raisbeck BM; Ritter MA
Acta Oncol; 2006; 45(6):717-27. PubMed ID: 16938815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
